STERIS plc (NYSE:STE) Forecasted to Earn Q4 2024 Earnings of $2.41 Per Share

STERIS plc (NYSE:STE) – Equities research analysts at Zacks Research cut their Q4 2024 earnings estimates for STERIS in a research report issued to clients and investors on Thursday, May 2nd. Zacks Research analyst R. Department now anticipates that the medical equipment provider will earn $2.41 per share for the quarter, down from their previous forecast of $2.42. The consensus estimate for STERIS’s current full-year earnings is $8.67 per share. Zacks Research also issued estimates for STERIS’s Q1 2025 earnings at $2.16 EPS and Q2 2026 earnings at $2.55 EPS.

A number of other research firms also recently commented on STE. Stephens reissued an “overweight” rating and issued a $250.00 price objective on shares of STERIS in a research note on Friday, February 9th. TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. KeyCorp began coverage on shares of STERIS in a research note on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price objective on the stock. StockNews.com downgraded shares of STERIS from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Finally, JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, STERIS currently has a consensus rating of “Hold” and an average target price of $239.60.

STERIS Price Performance

Shares of NYSE:STE opened at $212.87 on Monday. The stock has a market cap of $21.03 billion, a price-to-earnings ratio of 37.28 and a beta of 0.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. STERIS has a 12 month low of $185.22 and a 12 month high of $254.00. The stock’s 50 day moving average price is $217.58 and its 200 day moving average price is $216.01.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.17 by $0.05. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The company had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same period in the prior year, the business posted $2.02 EPS. The business’s revenue for the quarter was up 14.8% compared to the same quarter last year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Wednesday, June 12th. STERIS’s dividend payout ratio (DPR) is currently 36.43%.

Institutional Investors Weigh In On STERIS

Several hedge funds have recently made changes to their positions in STE. Williams Jones Wealth Management LLC. raised its stake in STERIS by 0.6% during the 1st quarter. Williams Jones Wealth Management LLC. now owns 605,576 shares of the medical equipment provider’s stock valued at $136,146,000 after purchasing an additional 3,585 shares during the period. Inspire Investing LLC acquired a new position in STERIS during the first quarter valued at $2,954,000. NorthRock Partners LLC lifted its stake in STERIS by 46.0% in the 1st quarter. NorthRock Partners LLC now owns 1,521 shares of the medical equipment provider’s stock worth $342,000 after acquiring an additional 479 shares in the last quarter. Stonebrook Private Inc. boosted its position in STERIS by 6.6% during the 1st quarter. Stonebrook Private Inc. now owns 2,940 shares of the medical equipment provider’s stock worth $661,000 after acquiring an additional 183 shares during the period. Finally, Forsta AP Fonden grew its stake in STERIS by 9.1% during the 1st quarter. Forsta AP Fonden now owns 21,500 shares of the medical equipment provider’s stock valued at $4,834,000 after acquiring an additional 1,800 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.